Zoono raises $176,000 to fund food shelf-life push into Asia
What's the deal? ZoonoDealroom has a profile for this one. Try Dealroom → Group (ASX: ZNO) has raised US$161.8K (≈$176,000) through a share placement to an existing shareholder, providing working capital as the antimicrobial technology company commercialises its food shelf-life extension products across Asia. It will issue 6,410,256 shares at 3.9 cents each under its ASX Listing Rule 7.1 capacity.
Why now? The raise follows a quarterly report disclosing a cash position of just US$49.8K at the end of September — less than one quarter of runway at current burn rates. Zoono flagged at the time that it was in talks with potential investors and partners.
What's the endgame? The funds will accelerate Zoono's push to supply shelf-life extension technology to food producers, distributors, and supermarket chains, with China, India, and Korea flagged as marketing priorities. Its ZXT range applies antimicrobial technology to fresh produce packaging, inhibiting microbial growth to extend shelf life.
The business, built with strategic partner OSY Group LimitedDealroom has a profile for this one. Try Dealroom →, has been Zoono's main commercial focus since demand for its surface sanitisers collapsed after the pandemic. In May, it secured US$776.5K in first orders for soft fruit from UK packaging supplier Sharpak.
The details: At 3.9 cents, the shares price at a discount to the 4.9 cents last traded on 17 October, which valued Zoono at roughly US$4.34M. A rights issue at the same price will follow, letting all shareholders participate; the placing shareholder has committed to take up its full entitlement.
What could go wrong? Zoono did not disclose the size or timing of the rights issue, leaving it unclear whether the company can extend runway past the current quarter. Converting UK trials into recurring orders, and repeating that across Asia, remains unproven.
The signal: A US$161.8K placement is a modest lifeline, not a war chest. For a company that pivoted hard after its sanitiser market evaporated, the raise buys time to prove the shelf-life bet can generate sustainable revenue before more capital is needed.
Read more: themarketfloor.news
Image credit: Nicola since 1972
